Thrombospondin-2 (TSP2) expression is inversely correlated with vascularity in glioma

European Journal of Cancer

Volumn 35, Issue 3, 1999, Pages 502-506

  Kazuno, M ^a   Tokunaga, T ^a   Oshika, Y ^a   Tanaka, Y ^a   Tsugane, R ^a   Kijima, H ^a   Yamazaki, H ^a   Ueyama, Y ^a   Nakamura, M ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Glioma; Thrombospondin

Indexed keywords

THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CANCER GRADING; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

ADULT; ANALYSIS OF VARIANCE; ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; LYMPHOKINES; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033105773     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00374-8     Document Type: Article

References (30)

1. Brem S. The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg. 23:1976;440-453.
2. Baenziger N.L., Brodie G.N., Majerus P.W. Isolation and properties of a thrombin sensitive protein of human platelets. J Biol Chem. 247:1972;2723-2731.
3. Lawler J. The structural and functional properties of thrombospondin. Blood. 67:1986;112-123.
4. Weinstat-Saalow D.L., Zabrenetzky V.S., VanHoutte K., Frazier W.A., Roberts D.D., Steeg P.S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumour growth, metastatic potential, and angiogenesis. Cancer Res. 54:1994;6504-6511.
5. Volpert O.V., Tolsma S.S., Pellerin S., et al. Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun. 217:(1):1995;326-332.
6. Zabrenetzky V., Harris C.C., Steeg P.S., Roberts D.D. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int J Cancer. 59:1994;191-195.
7. Vos H.L., Devarayalu S., de Vries Y., Bornstein P. Thrombospondin 3 (Thbs3), a new member of the thrombospondin family. J Biol Chem. 267:1992;12192-12196.
8. Lawler J., Duquette M., Whittaker C.A., Adams J.C., McHenry K., DeSimone D.W. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol. 120:1993;1059-1067.
9. Oldberg A., Antonsson P., Lindblom K., Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem. 267:1992;22346-22350.
10. Bornstein P., O'Rourke K., Wikstrom K., et al. A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem. 266:1991;12821-12824.
11. Bornstein P. Thrombospondins: structure and regulation of expression. FASEB J. 6:1992;3290-3299.
12. Laherty C.D., O'Rourke K., Wolf F.W., Katz R., Seldin M.F., Dixit V.M. Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J Biol Chem. 267:1992;3274-3281.
13. Hsu S.C., Volpert O.V., Steck P.A., et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res. 56:1996;5684-5691.
14. Oshika Y., Masuda K., Tokunaga T., et al. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin Cancer Res. 4:1998;1785-1788.
15. Tokunaga T, Nakamura M, Oshika Y, et al. Thrombospondin-2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer (in press).
16. Kleihues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumours. Brain Pathol. 3:1993;255-268.
17. Tokunaga T., Oshika Y., Abe Y., et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer. 77:1998;998-1002.
18. Grossfeld G.D., Ginsberg D.A., Stein J.P., et al. Thrombospondin-1 expression in bladder cancer: Association with P53 alterations, tumour angiogenesis, and tumour progression. J Natl Cancer Inst. 89:1997;219-227.
19. Graham C., Rivers J., Kerbel R., Stankiewicz K., White W. Extent of vascularisation as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol. 145:1994;510-514.
20. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
21. Weidner N., Carro P.R., Flax J., Blumenfeld W., Folkman J. Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
22. Maeda K., Chung Y.S., Takatsuka S., et al. Tumour angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol. 13:1995;477-481.
23. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., Angeletti C.A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 340:1992;145-146.
24. Kim K.J., Li B., Winer J., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:1993;841-844.
25. Saleh M., Stacker S.A., Wilks A.F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial sequence. Cancer Res. 56:1996;393-401.
26. Millauer B., Shawver L.K., Plate K.H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 367:1994;576-579.
27. Chan A.S., Leung S.Y., Wong M.P., et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol. 22:1998;816-826.
28. Oshika Y., Nakamura M., Tokunaga T., et al. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol. 12:1998;541-544.
29. Volpert O.V., Tolsma S.S., Pellerin S., et al. Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun. 217:1995;326-332.
30. Volpert O.V., Dameron K.M., Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene. 14:1997;1495-1502.